2017년 9월 27일 13:05

European Commission Approves Symtuza® for the Treatment of HIV-1 In Adults and Adolescents in Europe

Janssen-Cilag International NV (Janssen) today announced that the European Commission has approved the use of Symtuza® (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF])[1], a once-daily darunavir-based single-tablet regimen (S...

 전체 기업